Literature DB >> 23766488

Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.

Maurine A Leverstein-van Hall1, Karola Waar, Jan Muilwijk, James Cohen Stuart.   

Abstract

OBJECTIVES: The CLSI recommends a fixed 2 : 1 ratio of co-amoxiclav for broth microdilution susceptibility testing of Enterobacteriaceae, while EUCAST recommends a fixed 2 mg/L clavulanate concentration. The aims of this study were: (i) to determine the influence of a switch from CLSI to EUCAST methodology on Escherichia coli susceptibility rates; (ii) to compare susceptibility results obtained using EUCAST-compliant microdilution with those from disc diffusion and the Etest; and (iii) to evaluate the clinical outcome of patients with E. coli sepsis treated with co-amoxiclav in relation to the susceptibility results obtained using either method.
METHODS: Resistance rates were determined in three laboratories that switched from CLSI to EUCAST cards with the Phoenix system (Becton Dickinson) as well as in 17 laboratories that continued to use CLSI cards with the VITEK 2 system (bioMérieux). In one laboratory, isolates were simultaneously tested by both the Phoenix system and either disc diffusion (n = 471) or the Etest (n = 113). Medical and laboratory records were reviewed for E. coli sepsis patients treated with co-amoxiclav monotherapy.
RESULTS: Only laboratories that switched methodology showed an increase in resistance rates - from 19% in 2010 to 31% in 2011 (P < 0.0001). All isolates that tested susceptible by microdilution were also susceptible by disc diffusion or the Etest, but of 326 isolates that tested resistant by microdilution, 43% and 59% tested susceptible by disc diffusion and the Etest, respectively. Among the 89 patients included there was a better correlation between clinical response and measured MICs using the Phoenix system than the Etest.
CONCLUSIONS: EUCAST methodology resulted in higher co-amoxiclav E. coli resistance rates than CLSI methodology, but correlated better with clinical outcome. EUCAST-compliant microdilution and disc diffusion provided discrepant results.

Entities:  

Keywords:  Etest; broth microdilution; clinical outcomes; discs; surveillance

Mesh:

Substances:

Year:  2013        PMID: 23766488     DOI: 10.1093/jac/dkt218

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men.

Authors:  Amaia Aguirre-Quiñonero; M C Lecaroz Agara; A Canut Blasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-23       Impact factor: 3.267

2.  Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.

Authors:  B Rossi; J F Soubirou; F Chau; L Massias; S Dion; R Lepeule; B Fantin; A Lefort
Journal:  Antimicrob Agents Chemother       Date:  2015-11-02       Impact factor: 5.191

3.  Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.

Authors:  Karina-Doris Vihta; Nicole Stoesser; Martin J Llewelyn; T Phuong Quan; Tim Davies; Nicola J Fawcett; Laura Dunn; Katie Jeffery; Chris C Butler; Gail Hayward; Monique Andersson; Marcus Morgan; Sarah Oakley; Amy Mason; Susan Hopkins; David H Wyllie; Derrick W Crook; Mark H Wilcox; Alan P Johnson; Tim E A Peto; A Sarah Walker
Journal:  Lancet Infect Dis       Date:  2018-08-17       Impact factor: 25.071

4.  National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands.

Authors:  Wieke Altorf-van der Kuil; Annelot F Schoffelen; Sabine C de Greeff; Steven Ft Thijsen; H Jeroen Alblas; Daan W Notermans; Anne Lm Vlek; Marianne Ab van der Sande; Tjalling Leenstra
Journal:  Euro Surveill       Date:  2017-11

5.  High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain.

Authors:  Luis Ricardo Castellanos; Pilar Donado-Godoy; Maribel León; Viviana Clavijo; Alejandra Arevalo; Johan F Bernal; Arjen J Timmerman; Dik J Mevius; Jaap A Wagenaar; Joost Hordijk
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records.

Authors:  Chang Ho Yoon; Sean Bartlett; Nicole Stoesser; Koen B Pouwels; Nicola Jones; Derrick W Crook; Tim E A Peto; A Sarah Walker; David W Eyre
Journal:  J Antimicrob Chemother       Date:  2022-08-25       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.